Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) will likely be releasing its Q3 2026 results after the market closes on Monday, November 2nd. Analysts expect Tactile Systems Technology to post earnings of $0.30 per share and revenue of $91.99 million for the quarter. Investors are encouraged to explore the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Monday, November 2, 2026 at 5:00 PM ET.
Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) last announced its quarterly earnings results on Monday, August 10th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.20. Tactile Systems Technology had a net margin of 7.10% and a return on equity of 11.49%. The company had revenue of $85.70 million during the quarter, compared to the consensus estimate of $85.52 million. On average, analysts expect Tactile Systems Technology to post $1.10 EPS for the current fiscal year and $1.35 EPS for the next fiscal year.
Tactile Systems Technology Stock Performance
Shares of TCMD opened at $23.64 on Monday. Tactile Systems Technology has a 52 week low of $14.84 and a 52 week high of $37.77. The stock has a market capitalization of $535.45 million, a price-to-earnings ratio of 21.89 and a beta of 0.82. The stock has a fifty day moving average of $22.72 and a 200-day moving average of $25.13.
Wall Street Analysts Forecast Growth
Get Our Latest Analysis on Tactile Systems Technology
Insider Transactions at Tactile Systems Technology
In related news, CEO Sheri Dodd sold 10,978 shares of Tactile Systems Technology stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $29.44, for a total transaction of $323,192.32. Following the sale, the chief executive officer directly owned 232,907 shares in the company, valued at $6,856,782.08. This trade represents a 4.50% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 2.10% of the stock is currently owned by company insiders.
About Tactile Systems Technology
Tactile Systems Technology, doing business as Tactile Medical, develops and provides medical devices and services for people with chronic swelling and related conditions. The company focuses primarily on lymphedema and chronic venous insufficiency, conditions that can cause persistent fluid buildup in the limbs and trunk.
Its principal products include advanced pneumatic compression devices, such as the Flexitouch Plus system for the treatment of lymphedema and the Entre Plus system for home treatment of lymphedema and chronic venous insufficiency.
See Also
- Five stocks we like better than Tactile Systems Technology
- Newmont’s Record Quarter Shows Why Gold’s Floor Is the Real Story
- Albemarle Upgrade: Can Energy Storage Recharge Lithium’s Leader?
- Consumer Staples Are Up 12% This Year—These 3 Beverage Stocks Are Leading the Way
- Can Planet Fitness Get Its Growth Back in Shape?
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.
